Challenges included human resources-related problems, delays in supplies deliveries and an increase in production costs.
Five months after announcing it, GlaxoSmithKline confirmed it has completed the spin-off of its consumer division, which is now officially operating as Haleon. The name change applies to Glaxo’s manufacturing plant in Guayama. The new ...
Staffing turnovers, lack of raw materials and increased costs affected the sector in May.